Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Filings indexed 551 across all filing types
Latest filing 2023-08-11 Call Transcript
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on August 7, 2023, discussing Q1 FY24 un-audited financial results. It includes detailed management commentary on financial performance, business updates, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call, which is a full text record of the conference call. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full dialogue, not just a summary or announcement. Therefore, the correct classification is CT with high confidence.
2023-08-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a short communication addressed to stock exchanges regarding the availability of the audio recording of an earnings conference call for Q1 FY24 un-audited financial results. It references the earnings call held on August 7, 2023, and provides a link to the audio recording. The document does not contain the transcript itself, financial statements, or detailed financial data, but rather an announcement about the availability of the call recording. Given the short length (1589 characters) and the nature of the content, this is not the earnings release or the call transcript itself, but an announcement related to the earnings call. The best fitting category is Call Transcript (CT) because it relates to the earnings conference call, but since it only announces the audio recording availability and does not contain the transcript, it is closest to a Call Transcript announcement. However, since the classification options do not have a separate category for call recording announcements, and the document is about the earnings conference call audio recording, the most appropriate classification is Call Transcript (CT). Confidence is high due to clear references to earnings call and audio recording.
2023-08-07 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Earnings Presentation for Un-Audited Financial Results – Q1 FY2024" and references Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events including earnings presentations. The content includes detailed financial highlights for Q1 FY2024, operational and strategic highlights, CMD message, financial ratios, project updates, and ESG focus. It is a presentation format aimed at investors and stakeholders summarizing quarterly financial results and business updates. The document is about 15,000 characters long, contains substantive financial data and analysis for a quarter, and is clearly a presentation rather than a full quarterly report or earnings release press release. Therefore, the document fits best into the category of Investor Presentation (IP).
2023-08-05 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing the un-audited financial results for Q1 FY2024 of Meghmani Finechem Limited (now Epigral Limited). It includes detailed financial figures such as revenue, EBITDA, PAT, and operational highlights for the quarter ended June 30, 2023. The document references Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including financial results. The content is a comprehensive quarterly financial update with actual financial data and management commentary, not merely an announcement of a report or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2023-08-05 English
Updates
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding changes in the designation of company directors. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in directors or key managerial personnel. The content details the change in designation of several directors from Executive to Non-Executive roles and confirms no debarment by SEBI or other authorities. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement about changes in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length is 4545 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2023-08-05 English
Outcome of Board Meeting
Regulatory Filings
2023-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.